Topic: Avandia
Feds issue subpoena over Glaxo's diabetes pill Avandia, a month after FDA restricts its useBritish drug maker GlaxoSmithKline reported Thursday that its controversial diabetes drug Avandia is under investigation by federal and state law enforcement officials in the U.S.The announcement came less ...
Prolonged use of diabetes drug?Avandia ?a drug taken by millions of diabetics patient, for a longer period may be dangerous because it adversely affects on bones and also this drug may increase the chance of osteoporosis.The consumption of this drug also leads ...
Many people are suffering from Diabetes and the morbidity is stillrapidly increasing every year. Necessarily, every person should pay moreattention to personal lifestyle and healthcare to avoid diabetes.However, even though you are unlucky to cause the disease, you need notworry so much ...
My mother was a diabetic and that was over 45 years back.However even than after I reached 40 I was getting my Blood tested for Blood Sugar and it was like that for over 10 years.My Doctor who was a Doctor for ...
FDA has determined to significantly restrict the use of formulations that contain rosiglitazone (Avandia, Avandamet, and Avandaryl, GlaxoSmithKline [GSK]) to patients with Type 2 diabetes who cannot control their diabetes with other medications. FDA is also requiring GSK to commission an independent ...
In response to major concerns about heart risks, U.S. health officials on Thursday severely restricted use of the diabetes drug rosiglitazone (Avandia) to patients with type 2 diabetes who cannot control their disease on other medications. Avandia is also sold in combination ...
FDA") three top administrators (Janet Woodcock, Joshua Sharfstein and Margaret Hamburg) announced the agency's decision to limit patient access to the diabetes treatment drug, Avandia (whose chemical name, for those who care, is rosiglitazone). The European Union did the FDA one better ...
The Food and Drug Administration has chosen to leave Avandia, the GlaxoSmithKline diabetes drug, on the market, with restrictions. The FDA will require that GSK develop a restricted access program for Avandia under a risk evaluation and mitigation strategy, or REMS. Under ...
Recently, the American Food and Drug Administration (FDA) and some European agencies announced that they were not recommending continuation of a medication for diabetes, Avandia (generic name Rosiglitazone), as it was implicated in heart disease. Only if patients have tried every other ...
A news search on the word "Avandia," the diabetes drug, will pull up thousands of results, nearly all pertaining to the Food and Drug Administration's decision last week to keep this dangerous drug on the market, albeit with restrictions. Avandia, on the ...
